EVAHF
Established in 2011 and based in Vancouver, Canada, EGF Theramed Health Corp. specializes in providing pharmaceutical-grade psychedelic compounds. The company's focus is on developing these substances for the therapeutic management of a variety of mental health challenges, notably anxiety, post-traumatic stress disorder (PTSD), and both general and treatment-resistant forms of depression.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -0.01 | $0 | — |
| 2025 Q2 | -0.01 | $0 | -$64,387 |
| 2025 Q1 | -0.00 | $0 | -$24,142 |
| 2025 Q4 | -0.18 | $0 | $25,880 |
| 2025 Q3 | -0.01 | $0 | $3,854 |
| 2024 Q2 | -0.02 | $0 | -$141 |
| 2024 Q1 | -0.00 | $0 | $177 |
| 2024 Q4 | -0.01 | $0 | -$2,094 |